Literature DB >> 11423587

Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level.

Pierre M Ronco1, Marie-Alexandra Alyanakian2, Beatrice Mougenot1, Pierre Aucouturier2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11423587     DOI： 10.1681/ASN.V1271558

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  29 in total

1.  Treatment of light chain deposition disease with bortezomib and dexamethasone.

Authors:  Efstathios Kastritis; Magdalini Migkou; Maria Gavriatopoulou; Panos Zirogiannis; Valsamakis Hadjikonstantinou; Meletios A Dimopoulos
Journal:  Haematologica       Date:  2008-12-09       Impact factor: 9.941

2.  Portal hypertension related to light chain deposition disease of liver: an enlightening experience.

Authors:  Arunansu Talukdar; Kabita Mukherjee; Dibbendhu Khanra; Manjari Saha
Journal:  BMJ Case Rep       Date:  2013-05-29

3.  Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease.

Authors:  Camille Cohen; Bruno Royer; Vincent Javaugue; Raphael Szalat; Khalil El Karoui; Alexis Caulier; Bertrand Knebelmann; Arnaud Jaccard; Sylvie Chevret; Guy Touchard; Jean-Paul Fermand; Bertrand Arnulf; Frank Bridoux
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

4.  Gamma 1-heavy chain deposition disease accompanied by IgG kappa in serum, urine, and bone marrow.

Authors:  Keiichi Kaneko; Koichi Seta; Jun Soma; Takashi Kuwahara; Mitsuteru Koizumi; Yuko Kikuchi; Akira Sugawara; Kensei Yahata
Journal:  CEN Case Rep       Date:  2013-07-10

5.  Probable light- and heavy-chain deposition disease in a patient with nodular diabetic glomerulosclerosis.

Authors:  Noriko Nakamura; Ritsuko Katafuchi; Izumi Watanabe; Yusuke Kuroki; Itsuko Ishida; Kei Hori
Journal:  CEN Case Rep       Date:  2014-02-13

6.  Systemic and rapidly progressive light-chain deposition disease initially presenting as tubulointerstitial nephritis.

Authors:  Satoko Takahashi; Jun Soma; Izaya Nakaya; Mayumi Yahata; Tsutomu Sakuma; Hiroshi Yaegashi; Akiyoshi Sato; Masaharu Wano; Hiroshi Sato
Journal:  CEN Case Rep       Date:  2012-07-19

Review 7.  Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update.

Authors:  K O Alsaad; A M Herzenberg
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

8.  Unusual Presentation of Light Chain Deposition Disease: A Case Report.

Authors:  Disha Arora; Mayank Uppal; Vindu Amitabh; Usha Agrawal
Journal:  J Clin Diagn Res       Date:  2016-05-01

9.  Hypertension, renal failure, and edema in a 38-year-old man: light chain deposition disease; a case report and review of the literature.

Authors:  Sarmad Said; Chad J Cooper; Azikiwe C Nwosu; Jorge E Bilbao; German T Hernandez
Journal:  J Nephropathol       Date:  2014-04-01

10.  Urinary protein profiles in a rat model for diabetic complications.

Authors:  Daniela M Schlatzer; Jean-Eudes Dazard; Moyez Dharsee; Rob M Ewing; Serguei Ilchenko; Ian Stewart; George Christ; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2009-06-04       Impact factor: 5.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.